Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search


HIV Medicine Prices In The Developing World

NZ Subsidiary Response To Parent Company Reduction In HIV Medicine Prices In The Developing World

Alister Brown, managing director of Merck Sharp & Dohme (NZ) Ltd said today:

¡§All of us here at Merck Sharp & Dohme in New Zealand have followed the unfolding story and debate regarding HIV medicine access and prices in the developing world.

¡§This decision by Merck to significantly reduce prices of our HIV medicines to help speed access in developing countries is a welcome development.

¡§We¡¦re pleased to see our parent company take a leadership role in addressing this major issue and we hope this initiative will be followed by other pharmaceutical companies with HIV products and other organisations involved in delivery and funding of treatment.

¡§Over recent years, Merck Sharp & Dohme New Zealand has played a role in the worldwide effort to develop new Merck HIV medicines. New Zealand clinicians and patients have taken part in the clinical trials to determine the safety and effectiveness of these medicines.

¡§Both HIV medicines which are the subject of today¡¦s announcement, CRIXIVAN„¥ and STOCRIN„¥, are available fully funded in New Zealand. CRIXIVAN has been funded since 1997 and we were pleased to work successfully with Pharmac late last year and reach agreement for STOCRIN to be fully funded here from 1 January 2001.¡¨


© Scoop Media

Business Headlines | Sci-Tech Headlines


ScoopPro: Helping The Education Sector Get More Out Of Scoop

The ScoopPro professional license includes a suite of useful information tools for professional users of Scoop including some specifically for those in the education sector to make your Scoop experience better. More>>

Big Tax Bill Due: Destiny Church Charities Deregistered

The independent Charities Registration Board has decided to remove Destiny International Trust and Te Hahi o Nga Matamua Holdings Limited from the Charities Register on 20 December 2017 because of the charities’ persistent failure to meet their annual return obligations. More>>

57 Million Users' Data: Uber Breach "Utterly Preventatable"

Cybersecurity leader Centrify says the Uber data breach of 57 million customer and driver records - which the ride-hailing company hid for more than a year - was “utterly preventable”. More>>

Scoop 3.0: How You Can Help Scoop’s Evolution

We have big plans for 2018 as we look to expand our public interest journalism coverage, upgrade our publishing infrastructure and offer even more valuable business tools to commercial users of Scoop. More>>

Having A Cow? Dairy Product Prices Slide For Fourth Straight Auction

Dairy product prices fell at the Global Dairy Trade auction, retreating for the fourth straight auction amid signs of increased production... Whole milk powder fell 2.7 percent to US$2,778 a tonne. More>>


Statistics: Butter At Record $5.67/Block; High Vegetable Prices

Rising dairy prices have pushed food prices up 2.7 percent in the year to October 2017, Stats NZ said today. This followed a 3.0 percent increase in the year to September 2017. More>>


Science: New Research Finds Herbicides Cause Antibiotic Resistance

New University of Canterbury research confirms that the active ingredients of the commonly used herbicides, RoundUp, Kamba and 2,4-D (glyphosate, dicamba and 2,4-D, respectively), each alone cause antibiotic resistance at concentrations well below label application rates. More>>


  • Bill Bennett on Tech